The nucleotide sequence of the IgA1 hinge region in IgA nephropathy

被引:22
作者
Greer, MR
Barratt, J
Harper, SJ
Allen, AC
Feehally, J
机构
[1] Leicester Gen Hosp, Dept Nephrol, Leicester LE5 4PW, Leics, England
[2] Southmead Hosp, Richard Bright Renal Unit, Bristol, Avon, England
关键词
alpha 1 heavy chain; IgA1; glycosylation; mRNA; lectins;
D O I
10.1093/ndt/13.8.1980
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Mesangial IgA1 deposition is characteristic of IgA nephropathy (IgAN). Structural abnormalities of the IgA1 glycoprotein may play a key role in its mesangial deposition, particularly the recently described abnormalities of O-glycosylation of the IgA1 hinge region. The mechanism of abnormal O-glycosylation has not yet been elucidated; it is not clear whether there is an alteration in the amino acid sequence of the hinge region, modifying the number of O-glycosylation sites available, or whether there is a post-translational defect in the glycosylation process. Methods. The O-glycosylation of serum IgA1 from a series of patients with IgAN and matched controls was assessed by lectin binding assay. We then used dideoxy-sequencing of the PCR-amplified hinge region of the alpha 1 heavy chain gene to compare the hinge region nucleotide sequence in IgAN and controls. We also compared cDNA transcripts of alpha 1 hinge region mRNA to look for evidence for a transcriptional abnormality in IgAN. Results. Lectin binding assays confirmed that the IgAN subjects used in this study did indeed display the previously reported abnormality of IgA1 O-glycosylation. However, the hinge region nucleotide sequence of the alpha 1 gene was identical in IgAN and controls. There was also no difference in the sizes of cDNA transcripts of hinge region mRNA from patients with IgAN and controls. Conclusions. We found no evidence for any nucleotide sequence alteration or transcriptional abnormality of the al hinge region in IgAN, and we conclude that the O-glycosylation defect is post-translational.
引用
收藏
页码:1980 / 1983
页数:4
相关论文
共 50 条
[41]   Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study [J].
Bagchi, Soumita ;
Lingaiah, Raghavendra ;
Mani, Kalaivani ;
Barwad, Adarsh ;
Singh, Geetika ;
Balooni, Veena ;
Bhowmik, Dipankar ;
Agarwal, Sanjay Kumar .
PLOS ONE, 2019, 14 (03)
[42]   IgA Nephropathy Associated With Infliximab Treatment in Patients With Crohn's Disease: Study of IgA1 and IgA2 Expression in Glomeruli [J].
Mima, Akira ;
Nakamoto, Takahiro ;
Matsuki, Takamasa ;
Kido, Suguru ;
Saito, Yuta ;
Morikawa, Takaaki ;
Matsumoto, Keishi ;
Gotoda, Hidemasa ;
Lee, Shinji .
IN VIVO, 2025, 39 (03) :1731-1738
[43]   Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy [J].
Qi, Yuan-yuan ;
Zhou, Xu-jie ;
Cheng, Fa-juan ;
Zhang, Hong .
DISEASE MARKERS, 2016, 2016
[44]   Lysosome-mediated aggregation of galactose-deficient IgA1 with transferrin receptor 1 links to IgA nephropathy [J].
Si, Meijun ;
Fu, Jingpeng ;
Fang, Mengting ;
Lu, Yunfei ;
Huang, Junxuan ;
Li, Haojie ;
Wang, Peiyi ;
Liao, Maofu ;
Zhu, Jian ;
Li, Peiyao ;
Zhong, Wenzhao ;
Guo, Zhifei ;
Yang, Wei ;
Ye, Zhiming ;
Hu, Hongli ;
Yu, Xueqing .
NATURE COMMUNICATIONS, 2025, 16 (01)
[45]   Incompleteness of mucin-type sugar chain of human serum IgA1 as possible cause of IgA nephropathy [J].
Iwase, H ;
Hiki, Y .
TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1999, 11 (59) :113-118
[46]   IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells [J].
Novak, Jan ;
Kafkova, Leona Raskova ;
Suzuki, Hitoshi ;
Tomana, Milan ;
Matousovic, Karel ;
Brown, Rhubell ;
Hall, Stacy ;
Sanders, John T. ;
Eison, T. Matthew ;
Moldoveanu, Zina ;
Novak, Lea ;
Novak, Zdenek ;
Mayne, Richard ;
Julian, Bruce A. ;
Mestecky, Jiri ;
Wyatt, Robert J. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) :3451-3457
[47]   GALACTOSYLATION OF N-LINKED AND O-LINKED CARBOHYDRATE MOIETIES OF IGA1 AND IGG IN IGA NEPHROPATHY [J].
ALLEN, AC ;
HARPER, SJ ;
FEEHALLY, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1995, 100 (03) :470-474
[48]   Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells [J].
Wang, Y ;
Zhao, MH ;
Zhang, YK ;
Li, XM ;
Wang, HY .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (01) :168-175
[49]   The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease [J].
Terasaka, Tomohiro ;
Uchida, Haruhito A. ;
Umebayashi, Ryoko ;
Tsukamoto, Keiko ;
Tanaka, Keiko ;
Kitagawa, Masashi ;
Sugiyama, Hitoshi ;
Tanioka, Hiroaki ;
Wada, Jun .
BMC NEPHROLOGY, 2016, 17
[50]   Assay for galactose-deficient IgA1 enables mechanistic studies with primary cells from IgA nephropathy patients [J].
Reily, Colin ;
Rizk, Dana, V ;
Julian, Bruce A. ;
Novak, Jan .
BIOTECHNIQUES, 2018, 65 (02) :71-77